» Articles » PMID: 12202667

Palliative Chemotherapy or Watchful Waiting? A Vignettes Study Among Oncologists

Overview
Journal J Clin Oncol
Specialty Oncology
Date 2002 Aug 31
PMID 12202667
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the preferences of oncologists for palliative chemotherapy or watchful waiting and the factors considered important to that preference.

Methods: Sixteen vignettes (paper case descriptions), varying on eight patient and treatment characteristics, were designed to assess the oncologists' preferences. Their strength of preference was rated on a 7-point scale. An orthogonal main effects design provided a subset of all possible combinations of the characteristics, allowing estimations of the relative weights of the presented characteristics. A written questionnaire was sent to a random sample of oncologists (N = 1,235).

Results: The response rate was 67%, and 697 questionnaires were available for analysis. Eighty-one percent of the respondents were male. The mean age was 46 years. We found considerable variation among the oncologists. No major associations between physician characteristics and preferences were found. Of the patient and treatment characteristics affecting treatment preference, age was the strongest predictor, followed by the patient's wish to be treated and the expected survival gain. Other patient and treatment characteristics had a limited effect on preferences, except for psychologic distress, which had no independent impact.

Conclusion: Patients will encounter different decisions depending on their oncologists' preferences and their own personal background. Therefore, to ensure adequate information for decision-making processes, decision aids are proposed.

Citing Articles

Impact of palliative chemotherapy and best supportive care on overall survival and length of hospitalization in patients with incurable Cancer: a 4-year single institution experience in Japan.

Murakawa Y, Sakayori M, Otsuka K BMC Palliat Care. 2019; 18(1):45.

PMID: 31159782 PMC: 6547558. DOI: 10.1186/s12904-019-0428-3.


Patients' quality of life during active cancer treatment: a qualitative study.

Sibeoni J, Picard C, Orri M, Labey M, Bousquet G, Verneuil L BMC Cancer. 2018; 18(1):951.

PMID: 30286733 PMC: 6172766. DOI: 10.1186/s12885-018-4868-6.


How do oncologists make decisions about chemotherapy for their older patients with cancer? A survey of Australian oncologists.

Moth E, Kiely B, Naganathan V, Martin A, Blinman P Support Care Cancer. 2017; 26(2):451-460.

PMID: 28776149 DOI: 10.1007/s00520-017-3843-0.


Factors determining the patients' care intensity for surgeons and surgical nurses: a conjoint analysis.

Oostveen C, Vermeulen H, Nieveen van Dijkum E, Gouma D, Ubbink D BMC Health Serv Res. 2015; 15:395.

PMID: 26384492 PMC: 4575441. DOI: 10.1186/s12913-015-1052-4.


Differences in attitudes and beliefs toward end-of-life care between hematologic and solid tumor oncology specialists.

Hui D, Bansal S, Park M, Reddy A, Cortes J, Fossella F Ann Oncol. 2015; 26(7):1440-6.

PMID: 26041765 PMC: 4855240. DOI: 10.1093/annonc/mdv028.